US-based Inhalon Biopharma is set to launch a trial of its at-home nebulised treatment for respiratory syncytial virus (RSV) ...
Human Metapneumovirus (HMPV) is a respiratory virus that may not be on most folk’s radars, but it’s more common than you ...
Shionogi’s oral antiviral for respiratory syncytial virus (RSV) has met its primary endpoint in a Phase II study.
Hospitals in China have been 'overwhelmed' by outbreak says WHO as NHS says people with respiratory symptoms should 'limit ...
A virus rapidly spreading in China is also circulating in the United States, causing concern among health experts.
(Alliance News) - hVIVO PLC on Monday said it has signed a contract with Inhalon Biopharma Inc to test its antiviral candidate to treat respiratory syncytial virus. The London-based contract research ...
In the wake of multiple cases of human metapneumovirus (hMPV) in India, multiple questions about its causes and symptoms seem ...
A 4-year-old boy in Ahmedabad has been diagnosed with human metapneumovirus, increasing Gujarat's cases to eight. The child is in stable condition. The virus, spreading since 2001, resembles the ...
Effective immediately, only two people are permitted at the bedside of patients during the day and one person overnight at ...
Cases of a virus that caused concern when it appeared to be spreading widely in parts of China have now risen in the UK. The ...
Respiratory syncytial virus usually causes mild, cold-like symptoms in most people and is the leading cause of infant ...